Tools & Technical Insights
Each article in this series is paired with a working analytical model and a citable sample report — the same tools deployed in real client engagements.
5-Part Series · Articles + Working Models + Sample Reports
What growing pharma companies need, and where that expertise usually hides. The discipline that sits between good science and good business — and what it looks like when those three domains are integrated from the start.
Why the FDA's tighter specification was actually the best thing that happened to this product. A Monte Carlo simulation and DOE-driven negotiation framework for every CMC team facing a specification challenge.
Analytical Tools
Monte Carlo USP Stage failure probability forecasting with variability modeling.
FDA-compliant similarity factor for reformulations, process changes, and post-approval variations.
How Monte Carlo simulation delivered a global portfolio without hiring — and what that model looks like for a multi-site organization managing resources under genuine uncertainty.
A $3.5M estimate reduced to $2.6M. No headcount added. No scope deferred. The $900,000 came from understanding what the standard projection had failed to see — including site-specific burden rates, workflow-level cost modeling, and resource configurations stress-tested across hundreds of simulated portfolio scenarios.
Analytical Tools
Resource Optimizer — Coming Soon
Multi-site Monte Carlo resource model with sensitivity analysis, variation decomposition, and transfer functions. Available as browser interface and standalone application.
Get NotifiedHow Linear Programming delivers a defensible portfolio strategy when gut feel and spreadsheets can't — and why the tools that solve this problem have been hiding in plain sight for decades.
NPV rankings and committee judgment work until the portfolio crosses ~15 programs. Beyond that, the interactions between projects, resources, timelines, and commercial assumptions grow combinatorially. Efficient Frontier analysis, Linear Programming, and Genetic Algorithms solve exactly this class of problem. Pharma has not adopted them yet — outside of the very largest organizations.
Analytical Tools
Portfolio LP Optimizer
Linear Programming model for portfolios of 15–50 programs. Maximizes risk-adjusted ROI subject to budget, resource, and strategic constraints.
Efficient Frontier Analyzer
Maps risk-return trade-offs across all feasible portfolio combinations — borrowed from quantitative finance, applied to R&D.
What it actually takes to move a pharmaceutical development organization into the digital age — and where most companies make costly wrong turns. A human-centered DMADV framework for digital transformation in a regulated environment.
Having built a digital strategy from the ground up — one designed to serve commercial and regulatory objectives, not just scientific ones — this article covers prioritization, the tools that matter vs. the ones that exist because someone championed them, and what a sustainable digital roadmap looks like when emotion leaves the room.
Get Notified When PublishedWork With These Tools
These are not academic exercises. Each tool is deployed in real client engagements and produces a branded, citable report with failure probabilities, sensitivities, and regulatory interpretation built in.
Start a Conversation